Consolidated Statements of Cash Flows (Unaudited) (USD $)	9 Months Ended
	Sep. 30, 2011	Sep. 30, 2010
Cash Flows From Operating Activities:
Net loss	$ (7,910,226)	$ (2,999,947)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	29,877	104,065
Share-based compensation	566,301	143,045
Fair value of common stock issued for charitable contributions	0	113,400
Fair value of common stock and warrants issued for services	384,620	930,144
Fair value of options issued for services	0	59,471
Derivative warrant liability loss (gain)	2,258,679	(1,000,987)
Non-cash gain on extinguishment of financial advisor fee payable	0	(200,000)
Non-cash loss on extinguishment of debt	1,514	0
Non-cash interest expense	12,159	2,450
Non-cash loss on disposal of assets	2,731	0
Changes in assets and liabilities:
Accounts receivable	100,804	117,741
Prepaid expenses and other current assets	(250,911)	(36,541)
Accounts payable	(243,121)	(442,637)
Deferred revenue	(198,550)	(197,594)
Accrued expenses and other liabilities	356,991	(85,422)
Deposits and other assets	(10,566)	(1,380)
Net cash used in operating activities	(4,899,698)	(3,494,192)
Cash Flows from Investing Activities:
Purchases of property and equipment	(290,733)	(11,157)
Decrease in restricted cash	265,500	0
Net cash used in investing activities	(25,233)	(11,157)
Cash Flows From Financing Activities:
Proceeds from the exercise of warrants	1,250,824	0
Proceeds from issuance of common stock and warrants, net of expenses	1,121,124	2,311,157
Principal payments for capital lease obligations	(1,534)	(1,388)
Proceeds from issuance of Series D Convertible Preferred Stock, net of expenses	2,478,702	0
Proceeds from bridge notes	1,000,000	250,000
Repayment of bridge notes	(75,000)	0
Proceeds from exercise of stock options, net of forfeitures	66,790	0
Net cash provided by financing activities	5,840,906	2,559,769
Net increase (decrease) in cash and cash equivalents	915,975	(945,580)
Cash and cash equivalents, beginning of period	1,342,044	1,166,858
Cash and cash equivalents, end of period	2,258,019	221,278
Supplemental Disclosure of Cash Flow Information and Non-Cash Financing Transactions:
Cash paid for interest	1,581	2,124
Accretion of dividend on Series B Perpetual Redeemable Preferred Stock	142,761	93,700
Deemed dividend on beneficial conversion feature of Series D Convertible Preferred Stock	1,975,211	0
Issuance of common stock in settlement of short term note	25,000	0
Issuance of common stock in settlement of accounts payable	0	23,000
Issuance of common stock in connection with issuance of promissory notes	0	48,500
Conversion of notes payable and accrued interest into Series D Convertible Preferred Stock	1,006,000	0
Reclassification of derivative warrant liability to additional paid-in capital	2,242,431	200,357
Fair value of warrants issued for investor relations services	173,000	0
Fair value of common stock issued for short-term note extension	10,500	0
Fair value of warrants issued to financial advisors as financing costs	41,363	217,141
Cancellation of restricted Common Stock	5,250	0
Deemed dividend on repricing of Warrants	$ 87,500	$ 0